Skip to main content


Figure 4 | AIDS Research and Therapy

Figure 4

From: NGX-4010, a capsaicin 8% patch, for the treatment of painful HIV-associated distal sensory polyneuropathy: integrated analysis of two phase III, randomized, controlled trials

Figure 4

Percentage of patients with30% reduction in NPRS score from baseline to weeks 2– 12. Patients in the 30-minute treatment groups; analysis by subgroup: (A) gender; (B) baseline pain score; (C) concomitant neuropathic pain medication use; and (D) duration of HIV-DSP. *Concomitant medication was defined as in Figure 3.

Back to article page